Literature DB >> 20670568

Endovascular treatment for vertebral dissecting aneurysm presenting with subarachnoid hemorrhage.

M Tsuura1, T Terada, H Yokote, H Matsumoto, G Hyoutani, K Kubo, Y Ryujin, K Nakai, T Itakura.   

Abstract

We report results and problems of the endovascular treatment in 12 cases of intradural vertebral dissecting aneurysm presenting with subarachnoid hemorrhage. There were four complications related to interventional procedure and conventional angiography. In three patients (25%), VDAs ruptured immediately after injection of contrast media or hypertension during the interventional procedure, which caused respiratory arrest. In a case of bilateral VA dissection (8%), after proximal VA occlusion had been performed for unilateral VDA, contralateral dissection extended to the basilar artery resulting in brain stem infarct. We suggest that the incidence of rebleeding of VDA during angiography and embolization is higher than that of usual saccular aneurysms. Careful injection of contrast media and strict blood pressure control seems to be more important to prevent rebleeding in VDAs than intracranial saccular aneurysms. Since unilateral VA occlusion may extend contralateral dissection in a case of bilateral VA dissection, it is necessary to check contralateral VA dissection before VA occlusion.

Entities:  

Year:  2001        PMID: 20670568     DOI: 10.1177/15910199990050S138

Source DB:  PubMed          Journal:  Interv Neuroradiol        ISSN: 1591-0199            Impact factor:   1.610


  2 in total

Review 1.  Deconstructive and Reconstructive Techniques in Treatment of Vertebrobasilar Dissecting Aneurysms: A Systematic Review and Meta-Analysis.

Authors:  Ö Sönmez; W Brinjikji; M H Murad; G Lanzino
Journal:  AJNR Am J Neuroradiol       Date:  2015-05-07       Impact factor: 3.825

2.  Endovascular Treatment of the Huge Dissecting Aneurysms Involving the Basilar Artery by the Internal Trapping Technique: Technical Note.

Authors:  Shi-Qing Mu; Xin-Jian Yang; You-Xiang Li; Chu-Han Jiang; Zhong-Xue Wu
Journal:  Chin Med J (Engl)       Date:  2015-07-20       Impact factor: 2.628

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.